Table 5.
Lymphocyte proportions of Immune cells in all study groups at baseline and after pentavalent vaccination.
| Type of immune cell | Enrolment | Post pentavalent vaccination | ||||
|---|---|---|---|---|---|---|
| PT1 (N=33) | PT2 (N=80) | FT (N=80) | PT1 (N=24) | PT2 (N=55) | FT (N=54) | |
| CD4% (median and IQR) | 10.65 ± 5.97 (5.76–13.68) | 12.94 ± 7.88 (5.94–17.93) | 15.54 ± 7.88 (10.2–19.2) | 12.19 ± 5.558 (8.54–15.85) | 16.89 ± 7.7 (10.5–20.93) | 18.99 ± 6.86 (12.9–25.43) |
| CD8% (median and IQR) | 17.42 ± 10.27 (7.30–27.5) | 10.86 ± 8.33 (4.84–13.6) | 12.11 ± 7.14 (7.31–15.1) | 19.98 ± 8.19 (16.95–24.38) | 12.57 ± 6.07 (8.22–17.35) | 15.49 ± 6.33 (11.65–18.35) |
| B cell % (median and IQR) | 17.5 ± 9.93 (8.6–25.55) | 16.73 ± 8.70 (8.95–23.5) | 18.94 ± 10.23 (10.6–24.3) | 18.23 ± 7.90 (11.15–25.95) | 20.87 ± 8.83 (14.85–28.03) | 22.63 ± 8.61 (15.83–27.45) |
| Class switched B cells % (median and IQR) | 25.15 ± 14.53 (14.63–30.93) | 25.73 ± 13.91 (14.8–32.9) | 19.92 ± 11.95 (8.75–29.8) | 28.48 ± 9.501 (20.7–35.1) | 32.8 ± 15.38 (25.3–39.03) | 29.82 ± 8.32 (24.73–34.38) |
| Unswitched B cell% (median and IQR) | 73.07 ± 16.15 (63.35–82.95) | 73.75 ± 14.37 (66.4–85.2) | 79.86 ± 11.97 (70.2–91.25) | 69.15 ± 9.824 (60.48–77.7) | 65.88 ± 15.19 (60.5–73.23) | 70.18 ± 8.32 (65.63–75.27) |
| Memory B cell% (median and IQR) | 11.27 ± 15.17 (3.10–9.28) | 9.86 ± 13.83 (3.63–8.63) | 10.07 ± 10.33 (3.9–10.6) | 13.98 ± 12.66 (6.063–15.08) | 14.68 ± 16.57 (5.03–15.98) | 8.03 ± 3.61 (5.17–10.3) |
| Class switched memory B cell % (median and IQR) |
34.26 ± 22.91 (16.6–55.7) | 32.42 ± 20.58 (14.6–44.9) | 28.79 ± 17.97 (12.25–42.95) | 38.37 ± 22.23 (18.05–52.7) | 46.09 ± 22.26 (32.08–64.35) | 49.79 ± 15.24 (38.68–61.2) |
| Unswitched memory B cells % (median and IQR) |
64.17 ± 22.34 (43.75–79.98) | 66.98 ± 20.37 (54.8–83.8) | 71.21 ± 17.97 (57.05–87.75) | 59.95 ± 20.82 (47.3–73.3) | 53.01 ± 21.55 (35.65–67.58) | 50.52 ± 14.74 (38.8–61.33) |
| Myeloid dendritic cells (mDC)% (median and IQR) | 0.20 ± 0.12 (0.09–0.27) | 0.35 ± 0.24 (0.19–0.47) | 0.33 ± 0.22 (0.16–0.44) | 0.30 ± 0.19 (0.17–0.47) | 0.32 ± 0.19 (0.185–0.44) | 0.32 ± 0.21 (0.18–0.44) |
| Plasmacytoid dendritic cells (pDC)% (median and IQR) | 0.11 ± 0.09 (0.05–0.17) | 0.2 ± 0.15 (0.09–0.26) | 0.2 ± 0.14 (0.1–0.26) | 0.11 ± 0.06 (0.05–0.17) | 0.19 ± 0.19 (0.09–0.24) | 0.15 ± 0.09 (0.08–0.19) |
| Monocytes % (median and IQR) | 5.5 ± 3.82 (2.5–6.79) | 7.75 ± 4.0 (4.77–10.4) | 8.34 ± 4.24 (5.06–11.1) | 7.4 ± 3.8 (5.033–10.63) | 7.0 ± 3.4 (4.58–8.57) | 6.26 ± 3.09 (3.58–9.28) |